Novo Nordisk

Novo Nordisk is changing haemophilia. Every step of our journey is focused on improving treatment and care for people. Our formulation for haemophilia with inhibitors was an innovation of its time, but our commitment is not limited to just one innovation. With our strong pipeline and our partnerships with the haemophilia community around the world, we will continue to drive fundamental and ongoing change for people with haemophilia in the future.